GO
Loading...

Cramer's Homework: CLMT Doesn't Add Up

Friday, 16 Sep 2011 | 6:47 PM ET

Cramer sharpens his pencil on Calumet Specialty Products and says lackluster growth, plus unsteady cash flow, plus distribution problems, plus a spotty history, equals a stock investors should stay away.